                         SEQUENCE LISTING

<110>  OREGON HEALTH & SCIENCE UNIVERSITY
 
<120>  MODULATION OF T CELL RESPONSES BY UL18 OF HUMAN CYTOMEGALOVIRUS

<130>  4153.013PC01

<150>  US 62/889,310
<151>  2019-08-20

<160>  34    

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  PRT
<213>  artificial sequence

<220>
<223>  SIVrev MHC-E supertrope

<400>  1

Arg Arg Trp Arg Arg Arg Trp Gln Gln Leu Leu Ala Leu Ala Asp Arg 
1               5                   10                  15      


Ile Tyr Ser Phe Pro Asp Pro 
            20              


<210>  2
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVtat MHC-E supertrope

<400>  2

Thr Ser Ser Ala Ser Asn Lys Pro Ile Ser Asn Arg Thr Arg His Cys 
1               5                   10                  15      


Gln Pro Glu 
            


<210>  3
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVnef MHC-E supertrope

<400>  3

Ile Ser Met Arg Arg Ser Arg Pro Ser Gly Asp Leu Arg Gln Arg Leu 
1               5                   10                  15      


Leu Arg Ala 
            


<210>  4
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVnef MHC-E supertrope

<400>  4

Glu Lys Leu Ala Tyr Arg Lys Gln Asn Met Asp Asp Ile Asp Glu Glu 
1               5                   10                  15      


Asp Asp Asp 
            


<210>  5
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVnef MHC-E supertrope

<400>  5

Ala Gln Thr Ser Gln Trp Asp Asp Pro Trp Gly Glu Val Leu Ala Trp 
1               5                   10                  15      


Lys Phe Asp 
            


<210>  6
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVnef MHC-E supertrope

<400>  6

Tyr Val Arg Tyr Pro Glu Glu Phe Gly Ser Lys Ser Gly Leu Ser Glu 
1               5                   10                  15      


Glu Glu Val 
            


<210>  7
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVpol MHC-Ia supertrope

<400>  7

Gly Gly Ile Gly Gly Phe Ile Asn Thr Lys Glu Tyr Lys Asn Val Glu 
1               5                   10                  15      


Ile Glu Val Leu Gly Lys Arg 
            20              


<210>  8
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVpol MHC-Ia supertrope

<400>  8

Asn Thr Pro Thr Phe Ala Ile Lys Lys Lys Asp Lys Asn Lys Trp Arg 
1               5                   10                  15      


Met Leu Ile Asp Phe Arg Glu 
            20              


<210>  9
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVpol MHC-Ia supertrope

<400>  9

Trp Met Gly Tyr Glu Leu Trp Pro Thr Lys Trp Lys Leu Gln Lys Ile 
1               5                   10                  15      


Glu Leu Pro 
            


<210>  10
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVgag MHC-II supertrope

<400>  10

Leu Gly Leu Gln Lys Cys Val Arg Met Tyr Asn Pro Thr Asn Ile Leu 
1               5                   10                  15      


Asp Val Lys 
            


<210>  11
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SIVgag MHC-II supertrope

<400>  11

Tyr Met Gln Leu Gly Lys Gln Gln Arg Glu Lys Gln Arg Glu Ser Arg 
1               5                   10                  15      


Glu Lys Pro Tyr Lys Glu Val 
            20              


<210>  12
<211>  235
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Supertrope fusion protein

<400>  12

Met Arg Arg Trp Arg Arg Arg Trp Gln Gln Leu Leu Ala Leu Ala Asp 
1               5                   10                  15      


Arg Ile Tyr Ser Phe Pro Asp Pro Thr Ser Ser Ala Ser Asn Lys Pro 
            20                  25                  30          


Ile Ser Asn Arg Thr Arg His Cys Gln Pro Glu Ile Ser Met Arg Arg 
        35                  40                  45              


Ser Arg Pro Ser Gly Asp Leu Arg Gln Arg Leu Leu Arg Ala Glu Lys 
    50                  55                  60                  


Leu Ala Tyr Arg Lys Gln Asn Met Asp Asp Ile Asp Glu Glu Asp Asp 
65                  70                  75                  80  


Asp Ala Gln Thr Ser Gln Trp Asp Asp Pro Trp Gly Glu Val Leu Ala 
                85                  90                  95      


Trp Lys Phe Asp Tyr Val Arg Tyr Pro Glu Glu Phe Gly Ser Lys Ser 
            100                 105                 110         


Gly Leu Ser Glu Glu Glu Val Gly Gly Ile Gly Gly Phe Ile Asn Thr 
        115                 120                 125             


Lys Glu Tyr Lys Asn Val Glu Ile Val Leu Gly Lys Arg Asn Thr Pro 
    130                 135                 140                 


Thr Phe Ala Ile Lys Lys Lys Asp Lys Asn Lys Trp Arg Met Leu Ile 
145                 150                 155                 160 


Asp Phe Arg Glu Trp Met Gly Tyr Glu Leu Trp Pro Thr Lys Trp Lys 
                165                 170                 175     


Leu Gln Lys Ile Glu Leu Pro Leu Gly Leu Gln Lys Cys Val Arg Met 
            180                 185                 190         


Tyr Asn Pro Thr Asn Ile Leu Asp Val Lys Tyr Met Gln Leu Gly Lys 
        195                 200                 205             


Gln Gln Arg Glu Lys Gln Arg Glu Ser Arg Glu Lys Pro Tyr Lys Glu 
    210                 215                 220                 


Val Tyr Pro Tyr Asp Val Pro Asp Tyr Ala Asp 
225                 230                 235 


<210>  13
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 4 full peptide sequence

<400>  13

Leu Asp Ala Trp Glu Lys Ile Arg Leu Arg Pro Gly Gly Lys Lys 
1               5                   10                  15  


<210>  14
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 4 optimal minimal sequence

<400>  14

Asp Ala Trp Glu Lys Ile Arg Leu Arg 
1               5                   


<210>  15
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 29 full peptide sequence

<400>  15

Lys Lys Ala Gln Gln Ala Ala Ala Asp Thr Gly Asn Ser Ser Gln 
1               5                   10                  15  


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 29 optimal minimal sequence

<400>  16

Lys Ala Gln Gln Ala Ala Ala Asp Thr 
1               5                   


<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 36 full peptide sequence

<400>  17

Gln Met Val His Gln Ala Ile Ser Pro Arg Thr Leu Asn Ala Trp 
1               5                   10                  15  


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 36 optimal minimal sequence

<400>  18

His Gln Ala Ile Ser Pro Arg Thr Leu 
1               5                   


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 47 full peptide sequence

<400>  19

Asn Thr Met Leu Asn Thr Val Gly Gly His Gln Ala Ala Met Gln 
1               5                   10                  15  


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 37 optimal minimal sequence

<400>  20

Val Gly Gly His Gln Ala Ala Met Gln 
1               5                   


<210>  21
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 61 full peptide sequence

<400>  21

Ser Thr Leu Gln Glu Gln Ile Gly Trp Met Thr Asn Asn Pro Pro 
1               5                   10                  15  


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 61 optimal minimal sequence

<400>  22

Ser Thr Leu Gln Glu Gln Ile Gly Trp 
1               5                   


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 69 full peptide sequence

<400>  23

Ile Val Arg Met Tyr Ser Pro Val Ser Ile Leu Asp Ile Arg Gln 
1               5                   10                  15  


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 69 optimal minimal sequence

<400>  24

Arg Met Tyr Ser Pro Val Ser Ile Leu 
1               5                   


<210>  25
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide 119 full peptide sequence

<400>  25

Gln Lys Gln Glu Pro Ile Asp Lys Glu Leu Tyr Pro Leu Ala Ser 
1               5                   10                  15  


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVgag peptide optimal minimal sequence

<400>  26

Lys Gln Glu Pro Ile Asp Lys Glu Leu 
1               5                   


<210>  27
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVpol peptide 14 full peptide sequence

<400>  27

Ser Phe Ser Phe Pro Gln Ile Thr Leu Trp Gln Arg Pro Leu Val 
1               5                   10                  15  


<210>  28
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVpol peptide 28 full peptide sequence

<400>  28

Val Arg Gln Tyr Asp Gln Ile Leu Ile Glu Ile Cys Gly Lys Lys 
1               5                   10                  15  


<210>  29
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVpol peptide 81 full peptide sequence

<400>  29

Glu Pro Phe Arg Lys Gln Asn Pro Asp Ile Val Ile Tyr Gln Leu 
1               5                   10                  15  


<210>  30
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVpol peptide 148 full peptide sequence

<400>  30

Tyr Val Asp Gly Ala Ala Asn Arg Glu Thr Lys Leu Gly Lys Ala 
1               5                   10                  15  


<210>  31
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVpol peptide 180 full peptide sequence

<400>  31

Glu Glu His Glu Lys Tyr Ser Asn Trp Arg Ala Met Ala Ser 
1               5                   10                  


<210>  32
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIVnef peptide 28 full peptide sequence

<400>  32

Ile Leu Asp Leu Trp Val Tyr His Thr Gln Gly Tyr Phe Pro Asp 
1               5                   10                  15  


<210>  33
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  POL #41

<400>  33

Gly Phe Ile Asn Thr Lys Glu Tyr Lys Asn Val Glu Ile Glu Val 
1               5                   10                  15  


<210>  34
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  pol #90

<400>  34

Leu Pro Gln Gly Trp Lys Gly Ser Pro Ala Ile Phe Gln Tyr Thr 
1               5                   10                  15  


